China Universal Asset Management Company’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

China Universal Asset Management Company’s Portfolio KRTX Stock Details KRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-4,363	Closed	-$1.38M	–	452
2023 Q4	$1.38M	Buy	4,363 +3,392	+349%	+$659K	0.27%	88
2023 Q3	$164K	Buy	971 +481	+98%	+$90.4K	0.05%	162
2023 Q2	$106K	Buy	490 +22	+5%	+$4.71K	0.03%	149
2023 Q1	$85K	Buy	468 +119	+34%	+$22.8K	0.03%	132
2022 Q4	$68.6K	Buy	349 +31	+10%	+$6.65K	0.03%	130
2022 Q3	$72K	Buy	+318	New	+$64.4K	0.03%	117

Other funds holding KRTX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

China Universal Asset Management Company's KRTX Position: Q1 2024 in Review

China Universal Asset Management Company sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 4,363 shares — an estimated $1.38M sold.

China Universal Asset Management Company first reported a position in KRTX in Q3 2022 and held it in 6 quarters. The position peaked at $1.38M in Q4 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

China Universal Asset Management Company reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
China Universal Asset Management Company sold 4,363 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $1.38M.
China Universal Asset Management Company first reported a position in Karuna Therapeutics, Inc. Common Stock in Q3 2022 and held it in 6 quarters.
China Universal Asset Management Company's Karuna Therapeutics, Inc. Common Stock position peaked at $1.38M in Q4 2023.
2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on China Universal Asset Management Company's 13F filing for Q1 2024, filed 29 Apr 2024.